$10.9 Billion is the total value of HHLR ADVISORS, LTD.'s 74 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IQ | IQIYI INCsponsored ads | $1,082,848,000 | +30.3% | 46,694,629 | 0.0% | 9.90% | -11.6% | |
| BGNE | BEIGENE LTDsponsored adr | $1,030,974,000 | +53.0% | 5,472,259 | 0.0% | 9.42% | +3.8% | |
| UBER | UBER TECHNOLOGIES INC | $598,623,000 | +11.3% | 19,260,700 | 0.0% | 5.47% | -24.5% | |
| ESGR | ENSTAR GROUP LIMITED | $267,018,000 | -3.9% | 1,747,840 | 0.0% | 2.44% | -34.9% | |
| APLS | APELLIS PHARMACEUTICALS INC | $164,224,000 | +21.9% | 5,028,289 | 0.0% | 1.50% | -17.3% | |
| FGEN | FIBROGEN INC | $160,328,000 | +16.6% | 3,955,787 | 0.0% | 1.47% | -20.9% | |
| BBIO | BRIDGEBIO PHARMA INC | $153,645,000 | +12.4% | 4,711,604 | 0.0% | 1.40% | -23.7% | |
| TSLA | TESLA INC | $140,783,000 | +106.1% | 130,378 | 0.0% | 1.29% | +39.7% | |
| ZTO | ZTO EXPRESS CAYMAN INCsponsored ads a | $126,047,000 | +38.6% | 3,433,592 | 0.0% | 1.15% | -6.0% | |
| BEAM | BEAM THERAPEUTICS INCcl a | $83,059,000 | +55.6% | 2,966,403 | 0.0% | 0.76% | +5.4% | |
| GMAB | GENMAB A/Ssponsored ads | $50,835,000 | +59.9% | 1,500,000 | 0.0% | 0.46% | +8.6% | |
| BEDU | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $31,328,000 | +16.8% | 3,985,797 | 0.0% | 0.29% | -21.0% | |
| IGMS | IGM BIOSCIENCES INC | $25,550,000 | +30.0% | 350,000 | 0.0% | 0.23% | -11.7% | |
| GTHX | G1 THERAPEUTICS INC | $23,033,000 | +120.1% | 949,431 | 0.0% | 0.21% | +49.6% | |
| MOGU | MOGU INCspon ads | $18,805,000 | +57.2% | 10,446,970 | 0.0% | 0.17% | +6.8% | |
| RGNX | REGENXBIO INC | $16,794,000 | +13.7% | 456,000 | 0.0% | 0.15% | -22.6% | |
| GRUB | GRUBHUB INC | $11,908,000 | +72.6% | 169,386 | 0.0% | 0.11% | +17.2% | |
| HOOK | HOOKIPA PHARMA INC | $10,961,000 | +40.9% | 943,254 | 0.0% | 0.10% | -4.8% | |
| MRUS | MERUS N V | $9,654,000 | +33.0% | 600,000 | 0.0% | 0.09% | -10.2% | |
| EIDX | EIDOS THERAPEUTICS INC | $8,514,000 | -2.7% | 178,600 | 0.0% | 0.08% | -33.9% | |
| SOHU | SOHU COM LTDsponsored ads | $7,387,000 | +47.8% | 802,034 | 0.0% | 0.07% | +1.5% | |
| PASG | PASSAGE BIO INC | $6,849,000 | +73.5% | 250,616 | 0.0% | 0.06% | +18.9% | |
| TXG | 10X GENOMICS INC | $6,698,000 | +43.3% | 75,000 | 0.0% | 0.06% | -3.2% | |
| CJJD | CHINA JO-JO DRUGSTORES INC | $6,679,000 | -23.8% | 4,840,000 | 0.0% | 0.06% | -48.3% | |
| TCRR | TCR2 THERAPEUTICS INC | $4,960,000 | +98.5% | 322,903 | 0.0% | 0.04% | +32.4% | |
| CBMG | CELLULAR BIOMEDICINE GROUP I | $3,521,000 | -5.4% | 235,214 | 0.0% | 0.03% | -36.0% | |
| CVET | COVETRUS INC | $2,775,000 | +119.7% | 155,124 | 0.0% | 0.02% | +47.1% | |
| CIH | CHINA INDEX HLDGS LTDspnsrd ads a | $642,000 | +58.5% | 300,000 | 0.0% | 0.01% | +20.0% | |
| NEW | PUXIN LTDads | $651,000 | +20.6% | 126,145 | 0.0% | 0.01% | -14.3% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.